Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Cogent Biosciences (COGT) Return on Equity (2018 - 2026)

Cogent Biosciences' Return on Equity history spans 9 years, with the latest figure at 0.01% for Q1 2026.

  • Quarterly Return on Equity rose 1.0% to 0.01% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.01% through Mar 2026, up 1.0% year-over-year, with the annual reading at 0.01% for FY2025, 0.0% changed from the prior year.
  • Return on Equity came in at 0.01% for Q1 2026, up from 0.01% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.0% in Q3 2022 to a low of 0.02% in Q2 2025.
  • The 5-year median for Return on Equity is 0.01% (2024), against an average of 0.01%.
  • Year-over-year, Return on Equity decreased -1bps in 2025 and then rose 1bps in 2026.
  • Cogent Biosciences' Return on Equity stood at 0.01% in 2022, then tumbled by -32bps to 0.01% in 2023, then fell by -30bps to 0.01% in 2024, then increased by 24bps to 0.01% in 2025, then increased by 19bps to 0.01% in 2026.
  • Per Business Quant, the three most recent readings for COGT's Return on Equity are 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025).